American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Bioventus Inc. (BVS)

$14.96 -0.53% NASDAQ: BVS · 15-min delayed

DURHAM, North Carolina
Public · NASDAQ: BVS
940 employees

Visit website Follow

$799.4MMarket cap

$568.1MRevenue · FY2025

$22.7MNet income

940Employees

BVSNASDAQ

2021IPO

About Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: BVS
Employees: 940
IPO date: Feb 11, 2021
Headquarters: 4721 EMPEROR BOULEVARD, SUITE 100
DURHAM, North Carolina 27703
Phone: (919) 474-6700
Industry: Medical Devices
Website: Visit site

Incorporation record

Incorporated in: DE, United States
Registered office: Wilmington, US
Legal entity ID: 5299004SUU1OOMI1GA25

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Registry IDs

Ticker: BVS Nasdaq
SEC CIK: 1665988
LEI: 5299004SUU1OOMI1GA25
EIN: 810980861
SIC: 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Bioventus Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/bioventus-inc/"><img src="https://americancompanies.com/badge/bioventus-inc.svg" alt="Bioventus Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Bioventus Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $568.1M
Net income: $22.7M
Total assets: $683.6M
Market cap: $799.4M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: BVS

$14.96 -0.53%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$6.51 $15.26

52-week range

Market cap: $799.4M
Shares outstanding: 53.4M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Feb 11, 2021

Bioventus Inc. (BVS) Stock Price

Profitable — net income of $22.7M in FY2025.
Trading near its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Bioventus Inc..

Write a review

Newsroom

News about Bioventus Inc.

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference GlobeNewswire Inc. · 2026-06-02 · positive Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It Benzinga · 2026-05-22 · positive Orthobiologics Market to Surpass USD 9 Billion by 2031 Amid Rising Osteoarthritis Cases and Advancements in Regenerative Therapies, Says Mordor Intelligence GlobeNewswire Inc. · 2026-03-12 · positive Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity GlobeNewswire Inc. · 2025-08-04 · positive Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights GlobeNewswire Inc. · 2025-04-10 · positive Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034 GlobeNewswire Inc. · 2024-11-26 · neutral

News & sentiment via Polygon.io

FAQ

Bioventus Inc.: frequently asked questions

Is Bioventus Inc. an American company?

Bioventus Inc. is a US-based company headquartered in Durham, North Carolina, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Bioventus Inc. headquartered?

Bioventus Inc. is headquartered in Durham, North Carolina, United States.

Is Bioventus Inc. publicly traded?

Yes — Bioventus Inc. is a publicly traded company. Its stock trades under the ticker symbol BVS on the NASDAQ.

What does Bioventus Inc. do?

Bioventus Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore